Ciprolac® Vaca Seca

The good news against mastitis begins in the dry period.

Therapeutic
  • Bovinos
  • Unprecedented formulation with use for dry cows.
  • Broad spectrum of action.
  • Bactericidal.
  • Fast and high tissue distribution.
  • Intracellular action.
  • High concentration (400 mg).
  • Protection through all the dry period. 59 days of action.
  • Dry Cow Therapy associated to Sellat.
  • Low bacterial resistance.

Components

Each 10 g syringe contains:

Ciprofloxacin (Hydrochloride) .......... 400.00 mg

Vehicle q.s. .......... 10.00 g


Main Indications:

Ciprolac® Vaca Seca is efficient at the prevention and treatment of mastitis in cows in the dry period, caused especially by agents Corynebacterium bovis, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, Enterobacter aerogenes and Trueperella (Arcanobacterium) pyogenes.


Directions and Dosages:

After the last milking of lactation and asepsis of udder, administer through the intramammary route, the whole content of 01 syringe, which is, 10 g Ciprolac® Vaca Seca in every quarter of udder, which corresponds to 400 mg of Ciprofloxacin per treated quarter. It is recommended to massage the teat from bottom to top, at udder, after the application, for a better dispersion of the product at the mammary gland.


CAUTION: COMPLY WITH THE FOLLOWING GRACE PERIOD

BOVINE

SLAUGHTER: THE SLAUGHTER OF THE ANIMALS TREATED WITH THIS PRODUCT MUST ONLY BE CARRIED OUT 50 DAYS AFTER THE LAST APPLICATION.

MILK: THE MILK OF THE ANIMALS TREATED WITH THIS PRODUCT MUST NOT BE INTENDED FOR HUMAN CONSUMPTION FOR UP TO 59 DAYS AFTER THE LAST APPLICATION OF THIS PRODUCT.


Last update: 02-19-2020

Presentations:

  • Disposable plastic syringe containing 10g packed in a box containing 24 units.